| Product Code: ETC8881072 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market - Industry Life Cycle |
3.4 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market - Porter's Five Forces |
3.5 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.9 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
4 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders in Portugal |
4.2.2 Growing demand for personalized medicine |
4.2.3 Technological advancements in next-generation sequencing (NGS) technology |
4.3 Market Restraints |
4.3.1 High costs associated with NGS testing |
4.3.2 Regulatory challenges and compliance requirements |
4.3.3 Limited reimbursement policies for NGS testing |
5 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Trends |
6 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market, By Types |
6.1 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Sequencing By Synthesis, 2021- 2031F |
6.1.4 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Ion Semiconductor Sequencing, 2021- 2031F |
6.1.5 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Single-Molecule Real-time Sequencing, 2021- 2031F |
6.1.6 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Nano Pore Sequencing, 2021- 2031F |
6.1.7 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Other Sequencing Technologies, 2021- 2031F |
6.2 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.2.3 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Drug Discovery, 2021- 2031F |
6.2.4 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Agricultural and Animal Research, 2021- 2031F |
6.2.5 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Other Applications, 2021- 2031F |
6.3 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Academic Institutes and Research Centres, 2021- 2031F |
6.3.3 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Hospitals and Clinics, 2021- 2031F |
6.3.4 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Pharmaceutical and Biotechnology Companies, 2021- 2031F |
6.3.5 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Other End Users, 2021- 2031F |
6.4 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market, By Service |
6.4.1 Overview and Analysis |
6.4.2 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Human Genome Sequencing, 2021- 2031F |
6.4.3 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Single Cell Sequencing, 2021- 2031F |
6.4.4 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Microbial Genome-based Sequencing, 2021- 2031F |
6.4.5 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Gene Regulation Services, 2021- 2031F |
6.4.6 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Animal and Plant Sequencing, 2021- 2031F |
6.4.7 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Other Sequencing Services, 2021- 2031F |
6.5 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market, By Workflow |
6.5.1 Overview and Analysis |
6.5.2 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.5.3 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.5.4 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenues & Volume, By Data Analysis, 2021- 2031F |
7 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Import-Export Trade Statistics |
7.1 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Export to Major Countries |
7.2 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Imports from Major Countries |
8 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Key Performance Indicators |
8.1 Average turnaround time for NGS testing |
8.2 Number of new NGS testing applications introduced in the market |
8.3 Adoption rate of NGS testing among healthcare providers |
8.4 Rate of accuracy and reliability of NGS test results |
8.5 Percentage of RD investment in NGS technology and testing methods |
9 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market - Opportunity Assessment |
9.1 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By Service, 2021 & 2031F |
9.5 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Opportunity Assessment, By Workflow, 2021 & 2031F |
10 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market - Competitive Landscape |
10.1 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Revenue Share, By Companies, 2024 |
10.2 Portugal Clinical Next-Generation Sequencing (NSG) Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here